The Impact of Industry Funding on Randomized Controlled Trials of Biologic Therapies

<b>Background:</b> There has been substantial interest from the pharmaceutical industry to study and develop new biologic agents. Previous studies outside of the biologics field have demonstrated that industry funding has the potential to impact the design and findings of clinical trials...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Aaron M. Gazendam, David Slawaska-Eng, Nicholas Nucci, Om Bhatt, Michelle Ghert
Formaat: Artikel
Taal:English
Gepubliceerd in: MDPI AG 2022-02-01
Reeks:Medicines
Onderwerpen:
Online toegang:https://www.mdpi.com/2305-6320/9/3/18